ACIST Medical Systems ACIST Medical Systems is a company that provides diagnostic technologies enabling users to visualize, assess, and manage patient treatment. | ![]() Nova Biomedical Nova Biomedical is a company that develops, manufactures, and sells advanced technology blood testing analyzers. | ![]() Acutus Medical Acutus Medical is a team of dedicated medical scientists, biomedical engineers, there and other professionals focused on the development of medical technologies that will revolutionize the treatment strategies of patients with complex cardiac arrhythmias. | ||
Founding Date | Founding Date 1991 | Founding Date 2010 | Founding Date 1976 | Founding Date 2011 |
Type | Type Subsidiary | Type Subsidiary | Type Private | Type Public |
Tags | ||||
Locations | Locations Eden Prairie, US HQ Tokyo, JP Heerlen, NL Pleasanton, US | Locations Carlsbad, US HQ Carlsbad, US | Locations Waltham, US HQ Jardim Canada, BR Mississauga, CA Les Ulis, FR Mörfelden Walldorf, DE Lainate, IT Tokyo, JP see more | Locations Carlsbad, US HQ Zaventem, BE |
Employees | Employees 305 | Employees 4402% increase | Employees 1,2771% increase | Employees 881% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $171.6m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $20.2m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $103.6m (FY, 2020) | Cost of goods N/A | Cost of goods $19.1m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $67.9m (FY, 2020) | Gross profit N/A | Gross profit $1m (FY, 2024) |
Net income | Net income N/A | Net income ($18.6m) (FY, 2020) | Net income N/A | Net income ($9.5m) (FY, 2024) |

GenMark Diagnostics is a provider of multiplex molecular diagnostic solutions.
View company
Nova Biomedical is a company that develops, manufactures, and sells advanced technology blood testing analyzers.
View company
Acutus Medical is a team of dedicated medical scientists, biomedical engineers, there and other professionals focused on the development of medical technologies that will revolutionize the treatment strategies of patients with complex cardiac arrhythmias.
View company